LEADER 01556nam  2200385Ia 450 
001 9910698811003321
005 20090603152555.0
035   $a(CKB)5470000002397760
035   $a(OCoLC)369281538
035   $a(EXLCZ)995470000002397760
100   $a20090603d2006      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $ereports on the status of postmarketing study commitments : implementation of section 130 of the Food and Drug Administration Modernization Act of 1997
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :$cCenter for Biologics Evaluation and Research,$d[2006]
215   $a22 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on June 3, 2009).
300   $a"Procedural".
300   $a"February 2006".
517   $aGuidance for industry 
606   $aPharmaceutical industry$xGovernment policy$zUnited States
606   $aBiologicals$xGovernment policy$zUnited States
615  0$aPharmaceutical industry$xGovernment policy
615  0$aBiologicals$xGovernment policy
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698811003321
996   $aGuidance for industry$93434577
997   $aUNINA